Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Free Research Articles

Citations 261-270 of 789 total displayed.

Past content (since May 2004):

Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
Sigurdur Y. Kristinsson, Thomas R. Fears, Gloria Gridley, Ingemar Turesson, Ulf-Henrik Mellqvist, Magnus Björkholm, and Ola Landgren
Blood 2008; 112: 3582-3586. [Abstract] [Full text] [PDF]  

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma
Laura Rosiñol, José Antonio Pérez-Simón, Anna Sureda, Javier de la Rubia, Felipe de Arriba, Juan José Lahuerta, José David González, Joaquín Díaz-Mediavilla, Belén Hernández, Javier García-Frade, Dolores Carrera, Angel León, Miguel Hernández, Pascual Fernández Abellán, Juan Miguel Bergua, Jesús San Miguel, and Joan Bladé, for Programa para el Estudio y la Terapéutica de las Hemopatías Malignas y Grupo Español de Mieloma (PETHEMA/GEM)
Blood 2008; 112: 3591-3593. [Abstract] [Full text] [PDF]  

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
Chris Pepper, Thet Thet Lin, Guy Pratt, Saman Hewamana, Paul Brennan, Louise Hiller, Robert Hills, Rachel Ward, Jane Starczynski, Belinda Austen, Laura Hooper, Tatjana Stankovic, and Chris Fegan
Blood 2008; 112: 3807-3817. [Abstract] [Full text] [PDF]  

Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib
Feng-Ting Liu, Samir G. Agrawal, Zanyar Movasaghi, Peter B. Wyatt, Ihtesham U. Rehman, John G. Gribben, Adrian C. Newland, and Li Jia
Blood 2008; 112: 3835-3846. [Abstract] [Full text] [PDF]  

The GPIIb/IIIa (integrin {alpha}IIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend
Barry S. Coller and Sanford J. Shattil
Blood 2008; 112: 3011-3025. [Abstract] [Full text] [PDF]  

Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring
Ye-Xiong Li, Hui Fang, Qing-Feng Liu, Jiade Lu, Shu-Nan Qi, Hua Wang, Jing Jin, Wei-Hu Wang, Yue-Ping Liu, Yong-Wen Song, Shu-Lian Wang, Xin-Fan Liu, Xiao-Li Feng, and Zi-Hao Yu
Blood 2008; 112: 3057-3064. [Abstract] [Full text] [PDF]  

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories
Régis Peffault de Latour, Jean Yves Mary, Célia Salanoubat, Louis Terriou, Gabriel Etienne, Mohamad Mohty, Sophie Roth, Sophie de Guibert, Sebastien Maury, Jean Yves Cahn, and Gerard Socié, on behalf of the French Society of Hematology and of the French Association of Young Hematologists
Blood 2008; 112: 3099-3106. [Abstract] [Full text] [PDF]  

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
Antonio Palumbo, Sara Bringhen, Anna M. Liberati, Tommaso Caravita, Antonietta Falcone, Vincenzo Callea, Marco Montanaro, Roberto Ria, Antonio Capaldi, Renato Zambello, Giulia Benevolo, Daniele Derudas, Fausto Dore, Federica Cavallo, Francesca Gay, Patrizia Falco, Giovannino Ciccone, Pellegrino Musto, Michele Cavo, and Mario Boccadoro
Blood 2008; 112: 3107-3114. [Abstract] [Full text] [PDF]  

Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease
Bart Barlogie, Frits van Rhee, John D. Shaughnessy, Jr, Joshua Epstein, Shmuel Yaccoby, Mauricio Pineda-Roman, Klaus Hollmig, Yazan Alsayed, Antje Hoering, Jackie Szymonifka, Elias Anaissie, Nathan Petty, Naveen S. Kumar, Geetika Srivastava, Bonnie Jenkins, John Crowley, and Jerome B. Zeldis
Blood 2008; 112: 3122-3125. [Abstract] [Full text] [PDF]  

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
Miguel A. Sanz, Pau Montesinos, Edo Vellenga, Consuelo Rayón, Javier de la Serna, Ricardo Parody, Juan M. Bergua, Angel León, Silvia Negri, Marcos González, Concha Rivas, Jordi Esteve, Gustavo Milone, José D. González, Elena Amutio, Salut Brunet, J. García-Laraña, Dolors Colomer, María J. Calasanz, Carmen Chillón, Eva Barragán, Pascual Bolufer, and Bob Lowenberg
Blood 2008; 112: 3130-3134. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79

* Sign up for Collection Alerts

* Collected Resources Home

* Related collections:
 Special Departments
 ASH 50th Anniversary Reviews
 e-Blood
 Blood Work
 Brief Reports
 Controversies in Hematology
 Focus on Hematology
 Free Research Articles
 How I Treat
 Perspectives
 Plenary Papers
 Review Articles
 Reviews in Translational Hematology

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020